BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 23931427)

  • 1. Recommended iodine dose for multiphasic contrast-enhanced mutidetector-row computed tomography imaging of liver for assessing hypervascular hepatocellular carcinoma: multicenter prospective study in 77 general hospitals in Japan.
    Ichikawa T; Okada M; Kondo H; Sou H; Murakami T; Kanematsu M; Yoshikawa S; Shiosakai K; Hayakawa A; Awai K; Yoshimitsu K; Yamashita Y
    Acad Radiol; 2013 Sep; 20(9):1130-6. PubMed ID: 23931427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal dose of contrast medium for depiction of hypervascular HCC on dynamic MDCT.
    Fujigai T; Kumano S; Okada M; Hyodo T; Imaoka I; Yagyu Y; Ashikaga R; Ishii K; Murakami T
    Eur J Radiol; 2012 Nov; 81(11):2978-83. PubMed ID: 22305012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moderate versus high concentration of contrast material for aortic and hepatic enhancement and tumor-to-liver contrast at multi-detector row CT.
    Awai K; Inoue M; Yagyu Y; Watanabe M; Sano T; Nin S; Koike R; Nishimura Y; Yamashita Y
    Radiology; 2004 Dec; 233(3):682-8. PubMed ID: 15486215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal scan timing of hepatic arterial-phase imaging of hypervascular hepatocellular carcinoma determined by multiphasic fast CT imaging technique.
    Kagawa Y; Okada M; Yagyu Y; Kumano S; Kanematsu M; Kudo M; Murakami T
    Acta Radiol; 2013 Oct; 54(8):843-50. PubMed ID: 23761547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal arterial phase imaging for detection of hypervascular hepatocellular carcinoma determined by continuous image capture on 16-MDCT.
    Ma X; Samir AE; Holalkere NS; Sahani DV
    AJR Am J Roentgenol; 2008 Sep; 191(3):772-7. PubMed ID: 18716108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimally Required Iodine Dose for the Detection of Hypervascular Hepatocellular Carcinoma on 80-kVp CT.
    Goshima S; Kanematsu M; Noda Y; Kawai N; Kawada H; Ono H; Bae KT
    AJR Am J Roentgenol; 2016 Mar; 206(3):518-25. PubMed ID: 26901007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aortic and hepatic enhancement and tumor-to-liver contrast: analysis of the effect of different concentrations of contrast material at multi-detector row helical CT.
    Awai K; Takada K; Onishi H; Hori S
    Radiology; 2002 Sep; 224(3):757-63. PubMed ID: 12202710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of hypervascular hepatocellular carcinoma in cirrhotic liver: comparison of different concentrations of contrast material with multi-detector row helical CT--a prospective randomized study.
    Sofue K; Tsurusaki M; Kawasaki R; Fujii M; Sugimura K
    Eur J Radiol; 2011 Dec; 80(3):e237-42. PubMed ID: 21067880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypervascular hepatocellular carcinomas: bolus tracking with a 40-detector CT scanner to time arterial phase imaging.
    Sultana S; Awai K; Nakayama Y; Nakaura T; Liu D; Hatemura M; Funama Y; Morishita S; Yamashita Y
    Radiology; 2007 Apr; 243(1):140-7. PubMed ID: 17329690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal dose and injection duration (injection rate) of contrast material for depiction of hypervascular hepatocellular carcinomas by multidetector CT.
    Yanaga Y; Awai K; Nakayama Y; Nakaura T; Tamura Y; Funama Y; Aoyama M; Asada N; Yamashita Y
    Radiat Med; 2007 Jul; 25(6):278-88. PubMed ID: 17634881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of hypervascular hepatocellular carcinoma in cirrhotic liver by means of helical CT: comparison of different contrast medium concentrations within the same patient.
    Sultana S; Morishita S; Awai K; Kawanaka K; Ohyama Y; Nakayama Y; Imuta M; Arakawa A; Yamashita Y
    Radiat Med; 2003; 21(6):239-45. PubMed ID: 14743896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal contrast dose for depiction of hypervascular hepatocellular carcinoma at dynamic CT using 64-MDCT.
    Yanaga Y; Awai K; Nakaura T; Namimoto T; Oda S; Funama Y; Yamashita Y
    AJR Am J Roentgenol; 2008 Apr; 190(4):1003-9. PubMed ID: 18356448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal iodine dose for 3-dimensional multidetector-row CT angiography of the liver.
    Ichikawa T; Motosugi U; Morisaka H; Sou H; Onohara K; Sano K; Araki T
    Eur J Radiol; 2012 Sep; 81(9):2450-5. PubMed ID: 21708439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low contrast dose protocol involving a 100 kVp tube voltage for hypervascular hepatocellular carcinoma in patients with renal dysfunction.
    Nakaura T; Nagayama Y; Kidoh M; Nakamura S; Namimoto T; Awai K; Harada K; Yamashita Y
    Jpn J Radiol; 2015 Sep; 33(9):566-76. PubMed ID: 26162707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Image fusion in dual energy computed tomography for detection of hypervascular liver hepatocellular carcinoma: phantom and preliminary studies.
    Kim KS; Lee JM; Kim SH; Kim KW; Kim SJ; Cho SH; Han JK; Choi BI
    Invest Radiol; 2010 Mar; 45(3):149-57. PubMed ID: 20142749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing scan delays of fixed duration contrast injection in contrast-enhanced biphasic multidetector-row CT for the liver and the detection of hypervascular hepatocellular carcinoma.
    Kanematsu M; Goshima S; Kondo H; Nishibori H; Kato H; Yokoyama R; Miyoshi T; Hoshi H; Onozuka M; Moriyama N
    J Comput Assist Tomogr; 2005; 29(2):195-201. PubMed ID: 15772536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of optimal timing of arterial phase imaging for the detection of hypervascular hepatocellular carcinoma by using triple arterial phase imaging with multidetector-row helical computed tomography.
    Murakami T; Kim T; Kawata S; Kanematsu M; Federle MP; Hori M; Okada A; Kumano S; Sugihara E; Tomoda K; Nakamura H
    Invest Radiol; 2003 Aug; 38(8):497-503. PubMed ID: 12874516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aortic and hepatic enhancement at multidetector CT: evaluation of optimal iodine dose determined by lean body weight.
    Kondo H; Kanematsu M; Goshima S; Watanabe H; Onozuka M; Moriyama N; Bae KT
    Eur J Radiol; 2011 Dec; 80(3):e273-7. PubMed ID: 21195572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of the hepatic arterial phase at Gd-EOB-DTPA-enhanced hepatic dynamic MRI: comparison of the test-injection and the fixed-time delay method.
    Nakamura S; Nakaura T; Kidoh M; Utsunomiya D; Doi Y; Harada K; Uemura S; Yamashita Y
    J Magn Reson Imaging; 2013 Sep; 38(3):548-54. PubMed ID: 23744782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can low-dose CT with iterative reconstruction reduce both the radiation dose and the amount of iodine contrast medium in a dynamic CT study of the liver?
    Takahashi H; Okada M; Hyodo T; Hidaka S; Kagawa Y; Matsuki M; Tsurusaki M; Murakami T
    Eur J Radiol; 2014 Apr; 83(4):684-91. PubMed ID: 24418284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.